Literature DB >> 16688508

Validation of the Hungarian translation of Hospital Anxiety and Depression Scale.

Katalin Muszbek1, Anna Szekely, Eva Mária Balogh, Mária Molnár, Magdolna Rohánszky, Agnes Ruzsa, Katalin Varga, Melinda Szöllosi, Piroska Vadász.   

Abstract

OBJECTIVES: The Hospital Anxiety and Depression Scale (HADS) is a widely used screening instrument. The purpose of this study was to evaluate reliability and validity of the Hungarian translation.
METHODS: The English version of the HADS was translated using the 'forward-backward' procedure. The questionnaire was used in a large scale study of 715 Hungarian cancer patients along with other screening measures of psychological state and description of illness.
RESULTS: Translated items of the HADS questionnaire showed high internal consistency: Cronbach's alpha values for the subscales were 0.81 (anxiety) and 0.83 (depression). Factor analysis of the Hungarian version yielded an identical two-factor model to the English and German versions. Results of the known groups comparison showed that both subscales of the HADS discriminates well between sub-groups: decreasing performance status and more advanced disease stage showed significantly higher levels of anxiety and depression. Sufficient concurrent validity of the HADS depression subscale was found using five items from the Symptom List and the Hungarian version of the Beck Depression Scale.
CONCLUSIONS: Based on a detailed analysis of results we found the translated version of the HADS a reliable and valid self-assessment screening tool in medical practice.

Entities:  

Mesh:

Year:  2006        PMID: 16688508     DOI: 10.1007/s11136-005-3627-8

Source DB:  PubMed          Journal:  Qual Life Res        ISSN: 0962-9343            Impact factor:   4.147


  9 in total

Review 1.  International experiences with the Hospital Anxiety and Depression Scale--a review of validation data and clinical results.

Authors:  C Herrmann
Journal:  J Psychosom Res       Date:  1997-01       Impact factor: 3.006

2.  Toxicity and response criteria of the Eastern Cooperative Oncology Group.

Authors:  M M Oken; R H Creech; D C Tormey; J Horton; T E Davis; E T McFadden; P P Carbone
Journal:  Am J Clin Oncol       Date:  1982-12       Impact factor: 2.339

Review 3.  Depression in advanced disease: a systematic review Part 1. Prevalence and case finding.

Authors:  M Hotopf; J Chidgey; J Addington-Hall; K Lan Ly
Journal:  Palliat Med       Date:  2002-03       Impact factor: 4.762

Review 4.  Which depression screening tools should be used in palliative care?

Authors:  Mari Lloyd-Williams; Juliet Spiller; Jason Ward
Journal:  Palliat Med       Date:  2003-01       Impact factor: 4.762

Review 5.  The validity of the Hospital Anxiety and Depression Scale. An updated literature review.

Authors:  Ingvar Bjelland; Alv A Dahl; Tone Tangen Haug; Dag Neckelmann
Journal:  J Psychosom Res       Date:  2002-02       Impact factor: 3.006

Review 6.  Depression and anxiety in oncology: the psychiatrist's perspective.

Authors:  R M Berard
Journal:  J Clin Psychiatry       Date:  2001       Impact factor: 4.384

7.  The hospital anxiety and depression scale.

Authors:  A S Zigmond; R P Snaith
Journal:  Acta Psychiatr Scand       Date:  1983-06       Impact factor: 6.392

8.  The Hospital Anxiety and Depression Scale (HADS): translation and validation study of the Iranian version.

Authors:  Ali Montazeri; Mariam Vahdaninia; Mandana Ebrahimi; Soghra Jarvandi
Journal:  Health Qual Life Outcomes       Date:  2003-04-28       Impact factor: 3.186

9.  The Hospital Anxiety And Depression Scale.

Authors:  R Philip Snaith
Journal:  Health Qual Life Outcomes       Date:  2003-08-01       Impact factor: 3.186

  9 in total
  15 in total

1.  Relationship between religiosity and health: evidence from a post-communist country.

Authors:  Barna Konkolÿ Thege; János Pilling; András Székely; Mária S Kopp
Journal:  Int J Behav Med       Date:  2013-12

2.  Association between smoking behaviour and genetic variants of glial cell line-derived neurotrophic factor.

Authors:  Eszter Kotyuk; Nora Nemeth; Zsolt Ronai; Zsolt Demetrovics; Maria Sasvari-Szekely; Anna Szekely
Journal:  J Genet       Date:  2016-12       Impact factor: 1.166

3.  Latent structure and measurement invariance of the Hospital Anxiety and Depression Scale in cancer outpatients.

Authors:  Elisabeth L Zeilinger; Ingo W Nader; Wolfgang Wiedermann; Mencia R Gutierrez-Colosia; Matthias Unseld; Simone Lubowitzki; Markus Raderer; Philipp B Staber; Peter Valent; Alexander Gaiger
Journal:  Int J Clin Health Psychol       Date:  2022-05-26

4.  Breast Cancer Survivorship Programme: Follow-Up, Rehabilitation, Psychosocial Oncology Care. 1st Central-Eastern European Professional Consensus Statement on Breast Cancer.

Authors:  Zsuzsanna Kahán; István Szántó; Rita Dudás; Zsuzsanna Kapitány; Mária Molnár; Zsuzsa Koncz; Mónika Mailáth
Journal:  Pathol Oncol Res       Date:  2022-06-02       Impact factor: 2.874

5.  Psychometric evaluation of the Hospital Anxiety and Depression Scale in a large community sample of adolescents in Hong Kong.

Authors:  Ya-Fen Chan; Doris Y P Leung; Daniel Y T Fong; Chi-Ming Leung; Antoinette M Lee
Journal:  Qual Life Res       Date:  2010-04-07       Impact factor: 4.147

6.  Hungarian validation of the Buss-Perry Aggression Questionnaire-Is the short form more adequate?

Authors:  Szabolcs Zimonyi; Krisztian Kasos; Zsuzsa Halmai; Luca Csirmaz; Helga Stadler; Sándor Rózsa; Anna Szekely; Eszter Kotyuk
Journal:  Brain Behav       Date:  2021-01-24       Impact factor: 2.708

7.  A validation study of the Hospital Anxiety and Depression Scale (HADS) in a large sample of French employees.

Authors:  Christine Bocéréan; Emilie Dupret
Journal:  BMC Psychiatry       Date:  2014-12-16       Impact factor: 3.630

Review 8.  Screening for emotional distress in cancer patients: a systematic review of assessment instruments.

Authors:  Andrea Vodermaier; Wolfgang Linden; Christopher Siu
Journal:  J Natl Cancer Inst       Date:  2009-10-13       Impact factor: 13.506

9.  Glial cell line-derived neurotrophic factor (GDNF) as a novel candidate gene of anxiety.

Authors:  Eszter Kotyuk; Gergely Keszler; Nora Nemeth; Zsolt Ronai; Maria Sasvari-Szekely; Anna Szekely
Journal:  PLoS One       Date:  2013-12-06       Impact factor: 3.240

10.  Psychometric properties of the multidimensional health locus of control scale form C in a non-Western culture.

Authors:  Barna Konkolÿ Thege; Beatrix Rafael; Magda Rohánszky
Journal:  PLoS One       Date:  2014-09-09       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.